The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Publisher
Elsevier
Website
http://www.ebiomedicine.com/

Some content from Wikipedia, licensed under CC BY-SA

New research aids fight against treatment-resistant superbugs

Researchers at Simon Fraser University are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant bacterial infections. Superbugs are characterized as infection-causing bacteria ...

Using alveolar epithelia as a model for coronavirus infection

Before new drugs can be administered to people, researchers first have to investigate their effects using cell cultures and animal testing. Human cell cultures are increasingly being used as a model system for this purpose. ...